Automated Liquid Handling Robot
- Response deadline
- Aug 17, 2026 Due in 4 days
- Date posted
- Aug 13, 2026
- Source
- Open notice
Description
Amendment00001 The purpose of this amendment is to answer questions received in response to this solicitation and extend the due date. NO ADDITIONAL QUESTIONS WILL BE ANSWERED. All responses to this amendment are due by August 17, 2026, 12:00 pm. Eastern Time (ET). All interested parties should carefully review the attached questions and answers. NO additional questions will be answered. ALL TERMS AND CONDITIONS REMAIN UNCHANGED. The U.S. Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), has a requirement for the purchase of one (1) automated robotic liquid handling system capable of automating DNA shearing and AMPure bead cleanup workflows used in long-read sequencing library preparation. The system shall support automated processing of up to 96 samples in a 96-well plate format and be interoperable with the Government's existing Pacific Biosciences (PacBio) Sequel IIe sequencing environment and validated laboratory workflows. This acquisition is being conducted as a brand-name-or-equal procurement. Equal products must meet all stated salient characteristics, interoperability requirements, workflow compatibility requirements, and performance specifications. The requirement includes delivery, installation, operational verification, end-user training for a minimum of two users, consumables sufficient to process at least 200 samples, and a minimum 12-month manufacturer warranty. The system shall be new and unused; refurbished or remanufactured equipment will not be accepted. Delivery shall be made to the FDA CVM laboratory facility in Laurel, Maryland, within 60 days of award.
Classifications
Documents (6)
- SF30_Amendment01_CVM-2026-133678.pdf.pdf637 KBNot yet available
- CSS_Amend02_CVM-2026-133678.docx.docx51 KBNot yet available
- CSS__CVM-2026-133678.docx.docx48 KBNot yet available
- CSS__Amendment01__CVM-2026-133678.docx.docx67 KBNot yet available
- Amendment02_QA_75F40126Q00158.docx.docx38 KBNot yet available
- SF30-Amendment02.pdf.pdf600 KBNot yet available
Contacts
- reagan.davis@fda.hhs.gov3017960910
- iris.johnson1@fda.hhs.gov3017963353
Similar contracts
- 66--Post-Award Brand Name Justification - 68HERW26P0276
- X-ray DiffractometerMarylandDue Aug 27, 2026
- Amersham ImageQuant [800/500] Imaging System Due Aug 20, 2026
- EXG X-Series RF Analog Signal GeneratorTennesseeDue Aug 20, 2026
- Spectrum Two FT-IR Spectrometer PurchaseOhioDue Aug 18, 2026
- QuantStudio 5 qPCR System and Operational Consumables, Thermo Fisher Scientific - Brand Name OnlyCataniaDue Aug 28, 2026